{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:37:55Z","timestamp":1792690675099,"version":"4.5.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Risk factor analysis of long-term graft survival in kidney transplant recipients is usually based on Cox regression models of time to first occurrence of doubling of serum creatinine or graft loss (DSCGL). However, death is a competing cause of failure, and censoring patients who die could bias estimates. We therefore compared estimates of time to first event versus estimates that included death as a competing risk and recurrent events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>A Cox regression analysis of 1997\u20132002 data from the Assessment of Lescol in Renal Transplant (ALERT) trial population identified an eight-factor risk model, by analyzing time to first occurrence of DSCGL. The same factors were re-analyzed, allowing for death as competing. The probability of survival free of DSCGL was estimated; and two recurrent models (marginal and conditional) were used for time to events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Creatinine, systolic BP, and HLA-DR mismatches lost 33%\u201346% of their strength of association with DSCGL when death was included as a competing risk. Small changes were observed if recurrent events were analyzed in the marginal model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The relationship between serum creatinine and DSCGL was attenuated when death was considered as a competing risk; inclusion of recurrent events had little effect. These findings have important implications for analysis and trial design in populations at high mortality risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.03760412","type":"journal-article","created":{"date-parts":[[2012,11,16]],"date-time":"2012-11-16T00:10:54Z","timestamp":1353024654000},"page":"241-247","source":"Crossref","is-referenced-by-count":11,"title":["Model Comparisons of Competing Risk and Recurrent Events for Graft Failure in Renal Transplant Recipients"],"prefix":"10.2215","volume":"8","author":[{"given":"Ingar","family":"Holme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt C.","family":"Fellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G.","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallvard","family":"Holdaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20230811","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/(SICI)1097-0258(19970430)16:8<911::AID-SIM544>3.0.CO;2-I","article-title":"Marginal analysis of recurrent events and a terminating event.","volume":"16","author":"Cook","year":"1997","journal-title":"Stat Med"},{"key":"R2-12-20230811","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/(SICI)1097-0258(19970430)16:8<833::AID-SIM538>3.0.CO;2-2","article-title":"An overview of statistical methods for multiple failure time data in clinical trials.","volume":"16","author":"Wei","year":"1997","journal-title":"Stat Med"},{"key":"R3-12-20230811","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0962280206071926","article-title":"Wei, Lin and Weissfeld\u2019s marginal analysis of multivariate failure time data: Should it be applied to a recurrent events outcome?","volume":"16","author":"Metcalfe","year":"2007","journal-title":"Stat Methods Med Res"},{"key":"R4-12-20230811","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jacc.2009.08.035","article-title":"Total cardiovascular disease burden: Comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial.","volume":"54","author":"Tikkanen","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R5-12-20230811","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"R6-12-20230811","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2215\/CJN.06320611","article-title":"Predictors of sudden cardiac death: A competing risk approach in the hemodialysis study.","volume":"7","author":"Shastri","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R7-12-20230811","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1093\/ndt\/gfr163","article-title":"Inflammation-associated graft loss in renal transplant recipients.","volume":"26","author":"Dahle","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R8-12-20230811","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/01621459.1989.10478873","article-title":"Regression analysis of multivariate incomplete failure time data by modelling marginal distributions.","volume":"84","author":"Wei","year":"1989","journal-title":"J Am Stat Assoc"},{"key":"R9-12-20230811","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators: Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial.","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"R10-12-20230811","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/j.1600-6143.2005.01105.x","article-title":"Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: The ALERT extension study.","volume":"5","author":"Holdaas","year":"2005","journal-title":"Am J Transplant"},{"key":"R11-12-20230811","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.TP.0000147338.34323.12","article-title":"Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial.","volume":"79","author":"Fellstr\u00f6m","year":"2005","journal-title":"Transplantation"},{"key":"R12-12-20230811","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the Cox proportional hazards model.","volume":"84","author":"Lin","year":"1989","journal-title":"J Am Stat Assoc"},{"key":"R13-12-20230811","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/biomet\/68.2.373","article-title":"On the regression analysis of multivariate failure time data.","volume":"68","author":"Prentice","year":"1981","journal-title":"Biometrika"},{"key":"R14-12-20230811","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0002-8703(94)90679-3","article-title":"Hematocrit and the risk of cardiovascular disease\u2014the Framingham study: a 34-year follow-up.","volume":"127","author":"Gagnon","year":"1994","journal-title":"Am Heart J"},{"key":"R16-12-20230811","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra011295","article-title":"Strategies to improve long-term outcomes after renal transplantation.","volume":"346","author":"Pascual","year":"2002","journal-title":"N Engl J Med"},{"key":"R17-12-20230811","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1053\/j.ajkd.2005.12.030","article-title":"Prognostic associations between lipid markers and outcomes in kidney transplant recipients.","volume":"47","author":"Schaeffner","year":"2006","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201302000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:42:48Z","timestamp":1786369368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201302000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.03760412","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}